2. Search Result
Search Result
Results for "

L18I

" in MedChemExpress (MCE) Product Catalog:

2

Inhibitors & Agonists

1

Click Chemistry

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-163962
    L18I

    		PROTACs Btk Inflammation/Immunology
    L18I is a Btk-targeting PROTAC that reduces inflammation in autoimmune diseases. L18I consists of PROTAC target protein ligand IBT6A (HY-13036A), PROTAC Linker Propargyl-PEG3-alcohol (HY-41921) and E3 ubiquitin ligase ligand Lenalidomide-Br (HY-43722), where the active control of the target protein ligand is IBT6A-CO-ethyne (HY-163963), and the conjugate of E3 ubiquitin ligase ligand + Linker is Lenalidomide-C3-PEG3-N3 (HY-163964) .
    L18I
  • HY-163964
    Lenalidomide-C3-PEG3-N3

    		E3 Ligase Ligand-Linker Conjugates Cancer
    Lenalidomide-C3-PEG3-N3 is an E3 Ligase Ligand-Linker Conjugate. Lenalidomide-C3-PEG3-N3 can be used to synthesize L18I (HY-163962) .
    Lenalidomide-C3-PEG3-N3

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: